Back to Feed
ClinicalTrials.gov|Clinical Trial
Treating Parkinson's Disease Through Transplantation of Autologous Stem Cell-Derived Dopaminergic Neurons
Jeffrey S. Schweitzer, MD, PhD
Abstract
The goal of this clinical trial is to assess the safety and tolerability of the surgical transplantation of dopaminergic progenitor cells into the brains of participants with Parkinson's disease. The transplanted dopaminergic cells will be derived from the participant's own skin cells. Phase: PHASE1 Status: RECRUITING Conditions: Parkinson Disease Interventions: autologous dopaminergic cell implantation
Keywords
Parkinson Disease